Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bicycle Therapeutics Plc ADR (BCYC)

Bicycle Therapeutics Plc ADR (BCYC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bicycle Therapeutics Plc ADR BLOCKS A & B PORTWAY BUILDING GRANTA PARK GREAT ABINGTON CAMBRIDGE X0 CB21 6GS GBR

www.bicycletherapeutics.com P: 44-12-2326-1503

Description:

Bicycle Therapeutics plc is a clinical-stage biopharmaceutical company. It is focused on developing medicines, referred to as Bicycles(R) for diseases which are underserved by existing therapeutics. Bicycle Therapeutics plc is based in Cambridge, United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 676,568
Enterprise Value, $K 180,848
Shares Outstanding, K 30,043
Annual Sales, $ 26,980 K
Annual Net Income, $ -180,660 K
Last Quarter Sales, $ 5,330 K
Last Quarter Net Income, $ -49,100 K
EBIT, $ -189,950 K
EBITDA, $ -183,400 K
60-Month Beta 0.89
% of Insider Shareholders 10.20%
% of Institutional Shareholders 86.15%
Float, K 26,979
% Float 89.80%
Short Volume Ratio 0.52

Growth:

1-Year Return 15.06%
3-Year Return -27.35%
5-Year Return 0.00%
5-Year Revenue Growth 277.87%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.16 on 02/20/24
Latest Earnings Date 05/02/24 [--]
Earnings Per Share ttm -5.13
EPS Growth vs. Prev Qtr 7.94%
EPS Growth vs. Prev Year -14.85%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

BCYC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -57.80%
Return-on-Assets % -34.14%
Profit Margin % -669.61%
Debt/Equity 0.08
Price/Sales 25.25
Price/Cash Flow N/A
Price/Book 1.84
Book Value/Share 12.35
Interest Coverage -53.97
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar